CTOs on the Move

BabelBark

www.babelbark.com

 
BabelBark is the most comprehensive pet health management tool available, managing pets care, records and fitness all in one place. The BabelBark mobile app for pet parents links with the software platforms for pet businesses, shelters and veterinarians to help pets live the happiest, healthiest lives possible—by connecting everyone who cares for them! Whether you love, treat, groom, train, walk or sit for pets—BabelBark helps you do it even better.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Britthaven

Britthaven is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Britthaven is based in Kinston, NC. You can find more information on Britthaven at www.britthaven.com

KLO Professional Billing

KLO Professional Billing is a Willowbrook, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Relmada

Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.

Metamark

Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.

YMCA of Pierce and Kitsap Counties

Join the YMCA today to access state-of-the-art gyms and pools, free group fitness classes, family programs, child care, swim lessons, and much more.